These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29767575)

  • 1. Dart to the target: an alternative bull's eye parametric display for European Society of Cardiology / European Respiratory Society goal-orientated risk reduction strategy in pulmonary arterial hypertension.
    Kaymaz C; Akbal OY; Hakgor A; Tokgoz HC; Tanyeri S
    Pulm Circ; 2018; 8(3):2045894018780522. PubMed ID: 29767575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the European Society of Cardiology/European Respiratory Society derived three- and four-strata risk stratification models in pulmonary arterial hypertension: introducing an internet-based risk stratification calculator.
    Ahmed A; Ahmed S; Kempe D; Rådegran G
    Eur Heart J Open; 2023 Mar; 3(2):oead012. PubMed ID: 36959867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratification in pulmonary arterial hypertension.
    Weatherald J; Boucly A; Sitbon O
    Curr Opin Pulm Med; 2018 Sep; 24(5):407-415. PubMed ID: 30004992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification in adult and pediatric pulmonary arterial hypertension: A systematic review.
    Lokhorst C; van der Werf S; Berger RMF; Douwes JM
    Front Cardiovasc Med; 2022; 9():1035453. PubMed ID: 36440049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Risk of Disease Progression in Pulmonary Arterial Hypertension: Insights from an International Survey of Clinical Practice.
    Simons JE; Mann EB; Pierozynski A
    Adv Ther; 2019 Sep; 36(9):2351-2363. PubMed ID: 31313097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC/ERS guideline era.
    Zelt JGE; Sugarman J; Weatherald J; Partridge ACR; Liang JC; Swiston J; Brunner N; Chandy G; Stewart DJ; Contreras-Dominguez V; Thakrar M; Helmersen D; Varughese R; Hirani N; Umar F; Dunne R; Doyle-Cox C; Foxall J; Mielniczuk L
    Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34675044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology.
    Aktaa S; Gale CP; Brida M; Giannakoulas G; Kovacs G; Adir Y; Benza RL; Böhm M; Coats A; D'Alto M; Escribano-Subias P; Ferrari P; Galiè N; Gibbs JSR; Gin-Sing W; Hoeper MM; Humbert M; Lang IM; Maron BA; Meszaros G; Vonk Noordegraaf A; Price LC; Pepke-Zaba J; Rådegran G; Reis A; Sitbon O; Torbicki A; Ulrich S; Rosenkranz S; Delcroix M
    Eur J Heart Fail; 2023 Apr; 25(4):469-477. PubMed ID: 36924171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification strategy and assessment of disease progression in patients with pulmonary arterial hypertension: Updated Recommendations from the Cologne Consensus Conference 2018.
    Leuchte HH; Ten Freyhaus H; Gall H; Halank M; Hoeper MM; Kaemmerer H; Kähler C; Riemekasten G; Ulrich S; Schwaiblmair M; Ewert R
    Int J Cardiol; 2018 Dec; 272S():20-29. PubMed ID: 30266353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies.
    Benza RL; Gomberg-Maitland M; Elliott CG; Farber HW; Foreman AJ; Frost AE; McGoon MD; Pasta DJ; Selej M; Burger CD; Frantz RP
    Chest; 2019 Aug; 156(2):323-337. PubMed ID: 30772387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of renal function in mortality risk assessment for pulmonary arterial hypertension.
    Zelt JGE; Hossain A; Sun LY; Mehta S; Chandy G; Davies RA; Contreras-Dominguez V; Dunne R; Doyle-Cox C; Wells G; Stewart DJ; Mielniczuk LM
    J Heart Lung Transplant; 2020 Jul; 39(7):675-685. PubMed ID: 32336606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERS International Congress, Madrid, 2019: highlights from the Pulmonary Vascular Diseases Assembly.
    Ramjug S; Weatherald J; Sahay S; Khoury J; Foris V; Chandran N; Bokan A; Godinas L; Delcroix M
    ERJ Open Res; 2020 Oct; 6(4):. PubMed ID: 33083438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis.
    Hao Y; Thakkar V; Stevens W; Morrisroe K; Prior D; Rabusa C; Youssef P; Gabbay E; Roddy J; Walker J; Zochling J; Sahhar J; Nash P; Lester S; Rischmueller M; Proudman SM; Nikpour M
    Arthritis Res Ther; 2015 Jan; 17(1):7. PubMed ID: 25596924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
    Galiè N; Humbert M; Vachiery JL; Gibbs S; Lang I; Torbicki A; Simonneau G; Peacock A; Vonk Noordegraaf A; Beghetti M; Ghofrani A; Gomez Sanchez MA; Hansmann G; Klepetko W; Lancellotti P; Matucci M; McDonagh T; Pierard LA; Trindade PT; Zompatori M; Hoeper M
    Eur Respir J; 2015 Oct; 46(4):903-75. PubMed ID: 26318161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
    Galiè N; Humbert M; Vachiery JL; Gibbs S; Lang I; Torbicki A; Simonneau G; Peacock A; Vonk Noordegraaf A; Beghetti M; Ghofrani A; Gomez Sanchez MA; Hansmann G; Klepetko W; Lancellotti P; Matucci M; McDonagh T; Pierard LA; Trindade PT; Zompatori M; Hoeper M;
    Eur Heart J; 2016 Jan; 37(1):67-119. PubMed ID: 26320113
    [No Abstract]   [Full Text] [Related]  

  • 15. The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension.
    Simpson CE; Griffiths M; Yang J; Nies MK; Vaidya RD; Brandal S; Martin LJ; Pauciulo MW; Lutz KA; Coleman AW; Austin ED; Ivy DD; Nichols WC; Everett AD; Hassoun PM; Damico RL
    ERJ Open Res; 2021 Oct; 7(4):. PubMed ID: 34651041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the DETECT algorithm for detection of risk of pulmonary arterial hypertension in systemic sclerosis: data from a Czech tertiary centre.
    Soukup T; Pudil R; Kubinova K; Hromadkova L; Dusek J; Tosovsky M; Bradna P; Hrncir Z; Bures J
    Rheumatology (Oxford); 2016 Jan; 55(1):109-14. PubMed ID: 26320140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment in pulmonary arterial hypertension.
    Raina A; Humbert M
    Eur Respir Rev; 2016 Dec; 25(142):390-398. PubMed ID: 27903661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension: role of combination therapy.
    Meis T; Behr J
    Curr Vasc Pharmacol; 2011 Jul; 9(4):457-64. PubMed ID: 21143162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs.
    Valentin S; Maurac A; Sitbon O; Beurnier A; Gomez E; Guillaumot A; Textoris L; Fay R; Savale L; Jaïs X; Montani D; Picard F; Mornex JF; Prevot G; Chabot F; Humbert M; Chaouat A
    Eur Respir J; 2021 Oct; 58(5):. PubMed ID: 33875491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
    Hoeper MM; Kramer T; Pan Z; Eichstaedt CA; Spiesshoefer J; Benjamin N; Olsson KM; Meyer K; Vizza CD; Vonk-Noordegraaf A; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Huscher D; Pittrow D; Rosenkranz S; Grünig E
    Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28775047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.